Added to Email Alerts

Pediatric Dermatology

Latest News View All

Study Compares Skin Toxicities of MEK Inhibitors in Children

Medscape Medical News November 20, 2024
Comorbidities of Eczema Are Numerous

Medscape News UK November 15, 2024
SDPA 2024

Why Topical Retinoids Are Key to Every Acne Regimen

Medscape Medical News November 15, 2024
Levonorgestrel IUDs Linked to Higher Skin Side Effects

Medscape Medical News November 7, 2024
Weight Loss Interventions Improve Key Features of PCOS

Medscape Medical News November 5, 2024
Infant's Rash Defies Most Likely Diagnoses

Medscape News UK October 25, 2024
Parent Perceptions Drive Diets of Children With AD

Medscape Medical News October 25, 2024
Emerging Fungal Infections Demand All-Out Approach

Medscape Medical News October 24, 2024

View All

Perspective View All

What We Know About Salmon Sperm in Dermatology

Commentary November 15, 2024

The use of salmon sperm is an example of the recent trend toward a cellular approach in which cutaneous components are activated with the intention of stimulating tissue regeneration.
EADV 2024

Conference Coverage September 27, 2024
Gluconolactone

Commentary September 13, 2024
Managing the Side Effects of PIK3CA and mTOR Inhibitors

Article August 7, 2024

View All

Journal Articles View All

Shingles Prevention in Immunocompromised Dermatology Patients

Skin Therapy Letter November 3, 2023
Utilization of Topical Ruxolitinib in Dermatology

Skin Therapy Letter September 4, 2023
Laundry Detergent as a Cause of Allergic Contact Dermatitis

Cutis August 16, 2023
Evolving Story of JAK Inhibitors for Treating Alopecia Areata

Skin Therapy Letter August 3, 2023
Testosterone for HSDD in Postmenopausal Women

Menopause July 20, 2023
Mpox in Young Woman With No Epidemiologic Risk Factors

Emerging Infectious Diseases June 22, 2023

View All

Additional Resources

Medscape Drugs & Diseases

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC. This website also contains material copyrighted by 3rd parties.